Sorrento Therapeutics Inc (NASDAQ:SRNE)

16.68
Delayed Data
As of Jul 02
 -0.53 / -3.08%
Today’s Change
3.10
Today|||52-Week Range
18.28
+65.64%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 20.00, with a high estimate of 33.00 and a low estimate of 17.00. The median estimate represents a +19.90% increase from the last price of 16.68.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Sorrento Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.25
Sales
$1.0M
Reporting Date
Sep 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 14.94%
 
 
 
 
 
 
Growthannually 18.08%
 
 
 
 

Sales

Growthquarterly 2.35%
 
 
 
 
 
 
Growthannually 821.52%
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account